A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas

Yazmín Odia, Teri N. Kreisl, Dawit Aregawi, Ellen K. Innis, Howard A. Fine

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Fingerprint Dive into the research topics of 'A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas'. Together they form a unique fingerprint.

Medicine & Life Sciences